New drug combo aims to shrink kidney tumors before surgery
Disease control
Recruiting now
This study tests whether taking zanzalintinib (a pill) plus nivolumab (an IV drug) for 12 weeks can shrink advanced kidney tumors enough to allow surgery. About 69 adults with locally advanced or inoperable clear cell renal cell carcinoma will take part. After 12 weeks, doctors w…
Phase: PHASE2 • Sponsor: Qian Qin • Aim: Disease control
Last updated May 26, 2026 12:01 UTC